Lombard Odier Asset Management (Switzerland)’s Alexion Pharmaceuticals ALXN Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,224	Closed	-$776K	–	499
2021 Q2	$776K	Buy	4,224 +297	+8%	+$51K	0.04%	237
2021 Q1	$600K	Buy	+3,927	New	+$607K	0.04%	222
2020 Q4	–	Sell	-8,325	Closed	-$953K	–	369
2020 Q3	$953K	Buy	+8,325	New	+$898K	0.1%	151
2016 Q2	–	Sell	-444	Closed	-$62K	–	452
2016 Q1	$62K	Hold	444	–	–	0.01%	388
2015 Q4	$86K	Buy	+444	New	+$77.6K	0.01%	383
2015 Q2	–	Sell	-1,200	Closed	-$209K	–	464
2015 Q1	$209K	Buy	+1,200	New	+$217K	0.02%	364
2014 Q4	–	Sell	-73,700	Closed	-$12.2M	–	752
2014 Q3	$12.2M	Buy	73,700 +72,689	+7,190%	+$11.9M	0.31%	82
2014 Q2	$157K	Buy	+1,011	New	+$160K	0.02%	418

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s ALXN Position: Q3 2021 in Review

Lombard Odier Asset Management (Switzerland) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,224 shares — an estimated $776K sold.

Lombard Odier Asset Management (Switzerland) first reported a position in ALXN in Q2 2014 and held it in 8 quarters. The position peaked at $12.2M in Q3 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Lombard Odier Asset Management (Switzerland) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 4,224 Alexion Pharmaceuticals shares in Q3 2021, an estimated $776K.
Lombard Odier Asset Management (Switzerland) first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 8 quarters.
Lombard Odier Asset Management (Switzerland)'s Alexion Pharmaceuticals position peaked at $12.2M in Q3 2014.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q3 2021, filed 12 Nov 2021.